• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Treatment of hepatic fibrosis in rat treated with DMN by siRNA/HSP47 encapsulated in vitamin A conjugating liposome

Research Project

Project/Area Number 17590664
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionSapporo Medical University

Principal Investigator

SATO Yasushi  SAPPORO MEDICAL UNIVERSITY, SCHOOL OF MEDICINE, INSTRUCTOR, 医学部, 助手 (80343383)

Co-Investigator(Kenkyū-buntansha) KATO Junji  SAPPORO MEDICAL UNIVERSITY, SCHOOL OF MEDICINE, ASSOCIATE PROFESSOR, 医学部, 助教授 (20244345)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2005: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsHEPATIC FIBROSIS / HSP47 / siRNA / retinol / 肝線維化 / コラーゲン / in vivo
Research Abstract

To date, no modality has been approved for antifibrotic therapy of liver cirrhosis in humans, mainly due to insufficient specificity for particular target molecules or target cells. In the present study, we first confirmed substantial suppression of collagen secretion from normal rat kidney (NRK) fibroblasts by small interfering RNA (siRNA) for a 46-kDa collagen-binding glycoprotein-(gp46)(heat shock protein 47 of rat), a collagen-specific chaperon. Since hepatic stellate cells (HSC), which play a key role in fibrogenesis, are known to take up vitamin A (VA) through retinol-binding protein receptors (RBPRs), we then treated primary rat HSCs and a human HSC cell line (LI90) with carboxy-fluorescein (FAM)-labeled siRNA gp46 encapsulated in VA-coupled liposomes (VA-lip-siRNAgp46) in the presence of various concentrations of FBS, and affirmed that the fluorescence of these cells was appreciably suppressed by anti-RBP antibodies. Specific delivery of FAM-labeled VA-lip-siRNAgp46 to HSCs was also verified following i.v. injection in rats with liver cirrhosis induced by dimethylnitrosamine (DMN), since the fluorescence was mainly observed in HSC areas of the cirrhotic liver but scarcely in the liver parenchyma, lung, spleen or retina. When ^3H-VA-lip-siRNAgp46 was administered, radioactivity was seen mainly in the liver of DMN-treated rats, while in the normal rats, radioactivity in the liver was not prominent. Treatment of DMN rats with VA-lip-siRNAgp46 (i.v.) resulted in nearly complete histological resolution of liver cirrhosis, due to apoptosis of HSCs, and a 100% survival rate; in contrast, no untreated rats survived. This novel approach may be applicable not only to the therapy of liver cirrhosis, but also for treating fibrotic conditions in other organs, such as nephrosclerosis and chronic pancreatitis, in which stellate cells reportedly play an essential role.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (14 results)

All 2007 2006 2005

All Journal Article (13 results) Book (1 results)

  • [Journal Article] Normal restoration of rat liver cirrhosis employing siRNA/HSP47 encapsulated in vitamin A liposomes2007

    • Author(s)
      Y Sato et al.
    • Journal Title

      Hep Intl 1

      Pages: 209-209

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Ex vivo large-scale generation of human platelets from cord blood CD34+ cells.2006

    • Author(s)
      Matsunaga T, Kato J, et al.
    • Journal Title

      Stem Cells 24

      Pages: 2877-2887

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.2006

    • Author(s)
      Sato Y, Kato J, et al.
    • Journal Title

      Cancer Chemother Pharmacol 58・5

      Pages: 570-576

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor-alpha expression via activation of NF-kappaB.2006

    • Author(s)
      Sato Y, Kato J, et al.
    • Journal Title

      Gut 55・12

      Pages: 1801-1808

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A melioration of murine dextran sulfate sodium-induced colitis by ex vivo extracellular superoxide dismutase gene transfer.2006

    • Author(s)
      Oku T, Kato J, et al.
    • Journal Title

      Inflamm Bowel Dis 12・7

      Pages: 630-640

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Ex vivo large-scale generation of human platelets from cord blood CD34+ cells.2006

    • Author(s)
      Matsunaga T, Kato J, Sato Y et al.
    • Journal Title

      Stem Cells. 24

      Pages: 2877-2887

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.2006

    • Author(s)
      Sato Y, Kato J, et al.
    • Journal Title

      Cancer Chemother Pharmacol. 58・5

      Pages: 570-576

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor-alpha expression via activation of NF-kappaB.2006

    • Author(s)
      Sato Y, Kato J, et al.
    • Journal Title

      Gut. 55

      Pages: 1801-1808

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Amelioration of murine dextran sulfate sodium-induced colitis by ex vivo extracellular superoxide dismutase gene transfer.2006

    • Author(s)
      Oku T, Kato J, Sato Y et al.
    • Journal Title

      Inflamm Bowel Dis. 12・7

      Pages: 630-640

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] 肝星細胞のコラーゲン特異シャペロンHSP47を標的とした肝線維化抑制療法2006

    • Author(s)
      村瀬和幸, 加藤淳二, 佐藤康史ほか
    • Journal Title

      肝臓 47巻

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion.2005

    • Author(s)
      Sato Y, Kato J, et al.
    • Journal Title

      Blood 106・2

      Pages: 756-763

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor2005

    • Author(s)
      Takimoto R, Kato J, et al.
    • Journal Title

      Cancer Biol Ther. 4・4

      Pages: 421-428

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor.2005

    • Author(s)
      Takimoto R, Kato J, Sato Y et al.
    • Journal Title

      Cancer Biol Ther. 4・4

      Pages: 421-428

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Book] 星細胞のコラーゲン特異的分子シャペロンHSP47を標的とするsiRNAを用いた新しい肝線維化抑制療法.消化管疾患における自然免疫(innate immunity)(小俣政男編)2005

    • Author(s)
      佐藤康史
    • Total Pages
      5
    • Publisher
      アークメディア
    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi